• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

hsa-mir-106b-5p 在印度尼西亚前列腺癌患者液体生物标志物中的潜力。

The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia.

机构信息

Department of Biotechnology, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Department of Biomedical Science., Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Indonesia.

出版信息

Asian Pac J Cancer Prev. 2021 Mar 1;22(3):837-842. doi: 10.31557/APJCP.2021.22.3.837.

DOI:10.31557/APJCP.2021.22.3.837
PMID:33773548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8286673/
Abstract

PURPOSE

This study aims to explore the potential of hsa-mir-106b-5p as a new liquid biomarker for prostate cancer sufferers in Indonesia.

METHODS

Analysis of hsa-mir-106b-5p expression of two tissue samples from BPH patients and two PCa patients used NanoString nCounter Expression Assay then validated by qRT-PCR using 10 patient urine samples for prostate cancer and BPH. Furthermore, analysis of the role of hsa-mir-106b-5p in prostate cancer was carried out bioinformatically.

RESULTS

The results of this study indicated that the expression of hsa-mir-106b-5p in prostate cancer tissue was 1.23 times higher than that of BPH and urine of Indonesian patients (1.72 times). Moreover, this miRNA was upregulated in prostate cancer cells compared to normal cells 1.37 times. The hsa-mir-106b-5p appeared to be involved in the development of prostate cancer through the binding of genes involved in endoplasmic reticulum stress pathways and tumor suppressor genes.

CONCLUSION

hsa-mir-106b-5p could modulate prostate cancer by interfering with the endoplasmic reticulum stress repair pathways and decreasing the expression of tumor suppressor genes involved in many biological processes. These updates our understanding of the role of hsa-mir-106b-5p in cancer and its potential as a candidate of a biomarker for clinical diagnosis of prostate cancer.

摘要

目的

本研究旨在探索 hsa-mir-106b-5p 作为印度尼西亚前列腺癌患者新型液体生物标志物的潜力。

方法

使用 NanoString nCounter Expression Assay 分析 2 例 BPH 患者和 2 例 PCa 患者组织样本中 hsa-mir-106b-5p 的表达情况，并用 10 例前列腺癌和 BPH 患者的尿液样本进行 qRT-PCR 进行验证。此外，还通过生物信息学分析了 hsa-mir-106b-5p 在前列腺癌中的作用。

结果

本研究结果表明，前列腺癌组织中 hsa-mir-106b-5p 的表达水平比 BPH 和印度尼西亚患者的尿液高 1.23 倍（1.72 倍）。此外，该 miRNA 在前列腺癌细胞中的表达水平比正常细胞高 1.37 倍。hsa-mir-106b-5p 似乎通过与内质网应激途径和肿瘤抑制基因相关的基因结合，参与了前列腺癌的发生发展。

结论

hsa-mir-106b-5p 可能通过干扰内质网应激修复途径和降低参与许多生物过程的肿瘤抑制基因的表达，从而调节前列腺癌。这些发现更新了我们对 hsa-mir-106b-5p 在癌症中的作用及其作为前列腺癌临床诊断生物标志物候选物的潜力的认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/7cad0d765ff5/APJCP-22-837-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/77e2b17165e2/APJCP-22-837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/ce3064630d0a/APJCP-22-837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/4590b87d7c3b/APJCP-22-837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/ebacba92b788/APJCP-22-837-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/7cad0d765ff5/APJCP-22-837-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/77e2b17165e2/APJCP-22-837-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/ce3064630d0a/APJCP-22-837-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/4590b87d7c3b/APJCP-22-837-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/ebacba92b788/APJCP-22-837-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c21/8286673/7cad0d765ff5/APJCP-22-837-g005.jpg

相似文献

1
The Potential of hsa-mir-106b-5p as Liquid Biomarker in Prostate Cancer Patients in Indonesia.hsa-mir-106b-5p 在印度尼西亚前列腺癌患者液体生物标志物中的潜力。
Asian Pac J Cancer Prev. 2021 Mar 1;22(3):837-842. doi: 10.31557/APJCP.2021.22.3.837.
2
Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer.鉴定肿瘤相关成纤维细胞中的 miRNA 特征，以预测前列腺癌的复发。
Comput Biol Med. 2024 Sep;180:108989. doi: 10.1016/j.compbiomed.2024.108989. Epub 2024 Aug 13.
3
miRNA-21 as High Potential Prostate Cancer Biomarker in Prostate Cancer Patients in Indonesia.miRNA-21 作为印度尼西亚前列腺癌患者的高潜力前列腺癌生物标志物。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):1095-1099. doi: 10.31557/APJCP.2023.24.3.1095.
4
miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.尿液中miR-21-5p、miR-141-3p和miR-205-5p水平——用于识别前列腺癌和膀胱癌的有前景的生物标志物。
Prostate. 2019 Jan;79(1):88-95. doi: 10.1002/pros.23714. Epub 2018 Sep 7.
5
MiR-106b-5p: A Master Regulator of Potential Biomarkers for Breast Cancer Aggressiveness and Prognosis.miR-106b-5p：乳腺癌侵袭性和预后的潜在生物标志物的主调控因子。
Int J Mol Sci. 2021 Oct 15;22(20):11135. doi: 10.3390/ijms222011135.
6
Challenges in Cancer Biomarker Discovery Exemplified by the Identification of Diagnostic MicroRNAs in Prostate Tissues.癌症生物标志物发现的挑战，以前列腺组织中诊断 microRNAs 的鉴定为例。
Biomed Res Int. 2020 May 5;2020:9086829. doi: 10.1155/2020/9086829. eCollection 2020.
7
A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.一项关于与良性前列腺增生相比，前列腺癌中失调的错配修复基因分子信号的研究。
PLoS One. 2015 May 4;10(5):e0125560. doi: 10.1371/journal.pone.0125560. eCollection 2015.
8
Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.细胞游离尿液中用于前列腺癌的诊断和预后的 microRNA 生物标志物。
Eur Urol Focus. 2018 Dec;4(6):825-833. doi: 10.1016/j.euf.2017.02.018. Epub 2017 Mar 9.
9
Tumor-Suppressive Function of miR-30d-5p in Prostate Cancer Cell Proliferation and Migration by Targeting NT5E.miR-30d-5p 通过靶向 NT5E 抑制前列腺癌细胞增殖和迁移的肿瘤抑制功能。
Cancer Biother Radiopharm. 2018 Jun;33(5):203-211. doi: 10.1089/cbr.2018.2457.
10
Hsa_circ_0107593 Suppresses the Progression of Cervical Cancer Sponging hsa-miR-20a-5p/93-5p/106b-5p.人源环状RNA hsa_circ_0107593通过吸附人源微小RNA hsa-miR-20a-5p/93-5p/106b-5p抑制宫颈癌进展
Front Oncol. 2021 Jan 15;10:590627. doi: 10.3389/fonc.2020.590627. eCollection 2020.

引用本文的文献

1
miR‑106b‑5p in stage II left‑sided and right‑sided colon cancer and its association with the prognostic characteristics of patients.II期左、右侧结肠癌中的miR-106b-5p及其与患者预后特征的关联
Oncol Lett. 2024 Oct 17;29(1):11. doi: 10.3892/ol.2024.14758. eCollection 2025 Jan.
2
A panel based on three-miRNAs as diagnostic biomarker for prostate cancer.基于三种微小RNA的前列腺癌诊断生物标志物组合。
Front Genet. 2024 May 16;15:1371441. doi: 10.3389/fgene.2024.1371441. eCollection 2024.
3
Recent progress in the roles of microRNAs in pulmonary arterial hypertension associated with congenital heart disease.

本文引用的文献

1
Emerging Function and Clinical Values of Exosomal MicroRNAs in Cancer.外泌体微小RNA在癌症中的新兴功能及临床价值
Mol Ther Nucleic Acids. 2019 Jun 7;16:791-804. doi: 10.1016/j.omtn.2019.04.027. Epub 2019 May 15.
2
Role of Endoplasmic Reticulum Stress in the Anticancer Activity of Natural Compounds.内质网应激在天然化合物抗癌活性中的作用。
Int J Mol Sci. 2019 Feb 22;20(4):961. doi: 10.3390/ijms20040961.
3
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
微小 RNA 在先天性心脏病相关肺动脉高压中的作用的最新进展。
Narra J. 2024 Apr;4(1):e579. doi: 10.52225/narra.v4i1.579. Epub 2024 Feb 28.
4
Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression.Hsa-let-7c-5p、hsa-miR-130b-3p 和 hsa-miR-142-3p 作为黑色素瘤进展的新型 miRNA 生物标志物。
Genet Res (Camb). 2022 Jul 7;2022:5671562. doi: 10.1155/2022/5671562. eCollection 2022.
5
Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update.尿微小RNA及其在前列腺癌诊断中的意义：五年进展
Cancers (Basel). 2022 Jun 28;14(13):3157. doi: 10.3390/cancers14133157.
6
Evaluation of Diagnostic and Prognostic Value of hsa_circ_0084927 and Analysis of Associated ceRNA Network in Colorectal Cancer.hsa_circ_0084927在结直肠癌中的诊断和预后价值评估及相关ceRNA网络分析
Int J Gen Med. 2022 Apr 22;15:4357-4377. doi: 10.2147/IJGM.S355043. eCollection 2022.
STRING v11：具有增强覆盖范围的蛋白质-蛋白质相互作用网络，支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
4
Risk factors for infectious complications following transrectal ultrasound-guided prostate biopsy.经直肠超声引导下前列腺穿刺活检后感染性并发症的危险因素。
Infect Drug Resist. 2018 Sep 17;11:1491-1497. doi: 10.2147/IDR.S171162. eCollection 2018.
5
Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.白皮杉醇酸，一种天然三萜烯，通过激活 IRE-1/JNK、PERK/CHOP 和 TRIB3，引起去势抵抗性前列腺癌细胞中依赖内质网应激的细胞凋亡。
J Exp Clin Cancer Res. 2018 Sep 3;37(1):210. doi: 10.1186/s13046-018-0889-x.
6
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells.肿瘤细胞分泌的外泌体 miR-105 通过 MYC 依赖性代谢重编程促进肿瘤生长。
Nat Cell Biol. 2018 May;20(5):597-609. doi: 10.1038/s41556-018-0083-6. Epub 2018 Apr 16.
7
Toward a Shared Vision for Cancer Genomic Data.迈向癌症基因组数据的共同愿景。
N Engl J Med. 2016 Sep 22;375(12):1109-12. doi: 10.1056/NEJMp1607591.
8
Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.Notch1信号通路在人前列腺癌中的双重肿瘤抑制和促进功能
Oncotarget. 2016 Jul 26;7(30):48011-48026. doi: 10.18632/oncotarget.10333.
9
Prostate cancer markers: An update.前列腺癌标志物：最新进展。
Biomed Rep. 2016 Mar;4(3):263-268. doi: 10.3892/br.2016.586. Epub 2016 Jan 29.
10
A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation.一项功能筛选鉴定出了抑制DNA修复并使前列腺癌细胞对电离辐射敏感的微小RNA。
Nucleic Acids Res. 2015 Apr 30;43(8):4075-86. doi: 10.1093/nar/gkv273. Epub 2015 Apr 6.